This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Menu

Daniel Pinchuk, PhD
Oligonucleotide Team Leader, Chemical R&D at Teva
Speaker

Profile

Daniel Pinchuk earned his PhD in Chemistry from the Technion - Israel Institute of Technology in 2018. Then he began his career at Teva API as an Oligonucleotide Synthesis Team Leader, where he is focusing on development of various types of generic oligonucleotide therapeutics.

Agenda Sessions

  • Challenges of Generic Oligonucleotide Drug Substance Development

    , 16:00
    View Session

At this event

Prev
Next
Dr. Elias Post, PhD
Senior Scientist
Synaffix/Lonza

See Daniel at TIDES Europe: Oligonucleotide and Peptide Therapeutics